In the last trading session, 1.39 million shares of the Applied Therapeutics Inc (NASDAQ:APLT) were traded, and its beta was 2.01. Most recently the company’s share price was $8.93, and it changed around $0.28 or 3.24% from the last close, which brings the market valuation of the company to $1.04B. APLT currently trades at a discount to its 52-week high of $10.62, offering almost -18.92% off that amount. The share price’s 52-week low was $1.79, which indicates that the current value has risen by an impressive 79.96% since then. We note from Applied Therapeutics Inc’s average daily trading volume that its 10-day average is 1.99 million shares, with the 3-month average coming to 2.65 million.

Applied Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.17. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 0 recommended APLT as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Applied Therapeutics Inc is expected to report earnings per share of -0.22 for the current quarter.

Applied Therapeutics Inc (NASDAQ:APLT) trade information

Instantly APLT has showed a green trend with a performance of 3.24% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 10.05 on recent trading dayincreased the stock’s daily price by 11.14%. The company’s shares are currently up 166.57% year-to-date, but still down -9.80% over the last five days. On the other hand, Applied Therapeutics Inc (NASDAQ:APLT) is -0.67% down in the 30-day period. We can see from the shorts that 12.14 million shares have been sold at a short interest cover period of 7.18 day(s).

Applied Therapeutics Inc (APLT) estimates and forecasts

Applied Therapeutics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 110.61 percent over the past six months and at a 9.15% annual growth rate that is well below the industry average of 17.80%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 33.33% in revenue this quarter, and will report an increase of 74.63% in the next quarter. The year-over-year growth rate is expected to be -93.31%, down from the previous year.

Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 183.33k in revenue for the current quarter. 2 analysts expect Applied Therapeutics Inc to make 19.15M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 9.99M and 190k respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -98.17%. Forecasts for the next quarter put sales growth at 9,978.95%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.72%.

APLT Dividends

Applied Therapeutics Inc’s next quarterly earnings report is expected to be released in December.

Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 5.24% of Applied Therapeutics Inc shares, and 101.87% of them are in the hands of institutional investors. The stock currently has a share float of 107.50%. Applied Therapeutics Inc stock is held by 165.0 institutions, with FRANKLIN RESOURCES INC being the largest institutional investor. By 2024-06-30, it held 8.1496% of the shares, which is about 10.21 million shares worth $47.69 million.

VR ADVISER, LLC, with 7.6149% or 9.54 million shares worth $44.57 million as of 2024-06-30, holds the second largest percentage of outstanding shares.